Thank you, Mr. Chair.
I would like to thank the witnesses for being with us.
There is another extremely interesting and in many cases very urgent subject, since we are talking about rare diseases and access to drugs for a small part of the population.
I would like to know what Health Canada's mission is in relation to the approval and approach for rare diseases.
What is your mission with regard to this approach?